News
Anal Cancer
Bladder Cancer
Bone Cancer
Brain Cancer
Breast Cancer
Cancer of Unknown Primary
Cervical Cancer
Colon Cancer
Esophageal Cancer
Gastric Cancer
GIST
Head & Neck Cancer
Hodgkins Lymphoma
Leukemia
Acute Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Liver Cancer
Lung Cancer
Melanoma
Mesothelioma
Multiple Myeloma
Myelodysplastic Syndrome
MPN-PV-ET-MF
Neuroblastoma
Neuroendocrine Tumors
Non Hodgkins Lymphoma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Renal Cancer
Rectal Cancer
Sarcoma
Skin Care
Skin Cancer
Testicular Cancer
Thyroid Cancer
Triple Negative Breast Cancer
Uterine Cancer
About Us
Advertising
News
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Search
Acute Leukemia
March 8, 2009
Troxacitabine Effective for AML that has Stopped Responding to Therapy
Charles H. Weaver, MD
March 8, 2009
Medication Errors Frequent in Pediatric Patients with ALL
Charles H. Weaver, MD
March 8, 2009
Intravenous Oncaspar® Safe and Effective in Children with ALL
Charles H. Weaver, MD
March 8, 2009
Identified Mutations Associated with Outcomes in AML
Charles H. Weaver, MD
March 8, 2009
High-Dose Chemotherapy Improves Survival Time for Persons w/ Acute Lymphocytic
Charles H. Weaver, MD
March 8, 2009
Nexavar® May Be More Effective in AML with Specific Mutations
Charles H. Weaver, MD
Previous Page
1
…
7
8
9
Loading Comments...
Write a Comment...
Email (Required)
Name (Required)
Website
